J3380 Injection vedolizumab intravenous 1 milligrams
Also known as: vedolizumab, Entyvio, integrin inhibitor
Vedolizumab intravenous 1 milligram injection is a monoclonal antibody targeting alpha-4-beta-7 integrin for inflammatory bowel disease treatment.
In Plain Language
inflammatory bowel disease injection; Crohn's/colitis treatment
Clinical Context
Indicated for moderate to severe Crohn's disease and ulcerative colitis. Blocks alpha-4-beta-7 integrin adhesion molecule to reduce intestinal inflammation. Administered intravenously with induction and maintenance dosing.
RVU Information
CPT J3380 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J3380?
CPT J3380 (Injection vedolizumab intravenous 1 milligrams) is a J Codes (Drugs) code. Vedolizumab intravenous 1 milligram injection is a monoclonal antibody targeting alpha-4-beta-7 integrin for inflammatory bowel disease treatment.
How is J3380 administered?
CPT J3380 is administered by a healthcare provider, typically via injection or infusion. Indicated for moderate to severe Crohn's disease and ulcerative colitis. Blocks alpha-4-beta-7 integrin adhesion molecule to reduce intestinal inflammation. Administered intravenously with induction and maintenance dosing. It is used by Gastroenterology, Infusion Centers, Internal Medicine.
When is CPT J3380 used?
Indicated for moderate to severe Crohn's disease and ulcerative colitis. Blocks alpha-4-beta-7 integrin adhesion molecule to reduce intestinal inflammation. Administered intravenously with induction and maintenance dosing.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.